2 active not recruiting, 2 completed, 1 recruiting, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Active not recruiting 2, Completed 2, Recruiting 1, Unknown 1 |
Follow Synovitis: new trials by email Literature Review of Synovitis trials Research Report on Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery Indocyanine Green - Tenosynovial Giant Cell Tumor | Phase 4 | Recruiting | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 40 | 2026-01-02 | 2026-01-05 |
| A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis Efanesoctocog alfa - Haemophilia A (Moderate or Severe), Hemophilia, Classic | Phase 4 | Active not recruiting | Swedish Orphan Biovitrum | 37 | 2024-12-19 | 2026-04-30 |
| Intensive Replacement Treatment in Haemophilia Patients With Synovitis EHL-FVIII, FVIII concentrate - Hemophilia A | Phase 4 | Completed | Federico II University | 64 | 2022-03-01 | 2024-03-27 |
| Corticosteroid Meniscectomy Randomized Trial Zilretta Injectable Product or Placebo - Osteoarthritis, Knee, Meniscus Tear | Phase 4 | Active not recruiting | The Cleveland Clinic | 150 | 2021-05-27 | 2026-08-31 |
| Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib Pexidartinib - Tenosynovial Giant Cell Tumor | Phase 4 | Completed | Daiichi Sankyo | 32 | 2020-10-20 | 2024-12-30 |
| Targeting Synovitis in Early Rheumatoid Arthritis Musculoskeletal Ultrasound, 28 Joint Disease Activity Score - Rheumatoid Arthritis, Polyarthritis | Phase 4 | Unknown | NHS Greater Glasgow and Clyde | 110 | 2009-09-01 | 2009-09-10 |
Giant Cell Tumor of Tendon Sheath (2) · Hemophilia A (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Lymphoma, Follicular (1) · Osteoarthritis, Knee (1)
Joint Diseases (6) · Musculoskeletal Diseases (6) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Coagulation Protein Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Giant Cell Tumors (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Immune System Diseases (2) · Muscular Diseases (2)
Indocyanine Green (1) · Triamcinolone Acetonide (1) · pexidartinib (1)
Daiichi Sankyo (1) · Federico II University (1) · NHS Greater Glasgow and Clyde (1) · Shanghai Jiao Tong University Affiliated Sixth People's Hospital (1) · Swedish Orphan Biovitrum (1) · The Cleveland Clinic (1)
Italy (3) · Spain (2) · United States (2) · Australia (1) · China (1) · Hungary (1) · Netherlands (1) · Norway (1) · Sweden (1) · Taiwan (1) · United Kingdom (1)
Duncan R Porter, MBChB, MRCP (1) · Iain B McInnes, PhD, FRCP (1) · James E Dale, MBChB, MRCP (1) · Morgan Jones, MD, MPH (1)
PMID 21613624, PMID 24376248, PMID 27026689, PMID 28057477, PMID 29290809, PMID 31188797, PMID 32224746, PMID 35230489, PMID 35837703, PMID 36502615, PMID 37121591, PMID 37178368